The invention uses recombinant parvoviruses, and particularly recombinant
adeno-associated virus (rAAV) to deliver genes and DNA sequences for gene
therapy following manipulation of the therapeutic virus for packaging and
transport. The invention delivers therapeutic viral vectors via rAAV
affixed to support matrixes (i.e., sutures, surgically implantable
materials, grafts, and the like).